Bafna Pharmaceuticals Limited (BOM:532989)
India · Delayed Price · Currency is INR 163.35
+6.85 (4.38%)
At close: Jun 19, 2026
Bafna Pharmaceuticals Market Cap
Bafna Pharmaceuticals has a market cap or net worth of 3.79 billion as of June 18, 2026. Its market cap has increased by 113.64% in one year.
Market Cap
3.79B
Enterprise Value
4.14B
Revenue
1.51B
Ranking
n/a
PE Ratio
34.14
Stock Price
163.35
Market Cap Chart
Since March 2, 2020, Bafna Pharmaceuticals's market cap has increased from 10.88M to 3.79B, an increase of 34,723.91%. That is a compound annual growth rate of 153.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 19, 2026 | 3.79B | 6.28% |
| Dec 31, 2025 | 3.57B | 91.03% |
| Dec 31, 2024 | 1.87B | -14.24% |
| Dec 29, 2023 | 2.18B | -8.68% |
| Dec 30, 2022 | 2.38B | -33.96% |
| Dec 31, 2021 | 3.61B | -10.71% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Mar 2, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Amanta Healthcare | 5.13B |
| Jenburkt Pharmaceuticals | 5.07B |
| Albert David | 4.05B |
| Medico Remedies | 3.53B |
| Trident Lifeline | 2.96B |
| Medicamen Biotech | 2.85B |
| Astonea Labs | 2.82B |
| Gennex Laboratories | 2.58B |